Aida Pharmaceuticals, Inc. (AIDA)

Market Cap	8.13K +50.5%
Revenue (ttm)	40.51M +41.3%
Net Income	-2.18M
EPS	-0.08
Shares Out	27.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.0003
Previous Close	0.0002
Day's Range	0.0003 - 0.0003
52-Week Range	0.0002 - 0.0003
Beta	22.47
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Aida Pharmaceuticals

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pha...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: AIDA

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error